Parliament Workbench
Data: Motions & questions to 19 Nov 2026

Written Question · S5W-03445 · Session 5

Further to the answer to question S5W-00491 by Shona Robison on 16 June 2016, what communication it has had with the (a) Medicines and Heal…

Answered Asked by Neil Findlay Lab Lodged 4 Oct 2016

The question

To ask the Scottish Government, further to the answer to question S5W-00491 by Shona Robison on 16 June 2016, what communication it has had with the (a) Medicines and Healthcare Products Regulatory Agency and (b) UK Government regarding action that is being taken to ensure that counterfeit medical products and medicines are not being used in the NHS.

The answer

Answered by Shona Robison on 1 Nov 2016 · 28 days after it was lodged, on time

The Medicines and Healthcare products Regulatory Agency (MHRA) is responsible for regulating medical devices in the UK. Any allegations regarding the use of counterfeit material, or any other adverse event, are investigated by the MHRA and device and drug alerts are issued as required.
With reference to the alleged use of counterfeit material in Boston Scientific's trans-vaginal mesh products, I can confirm that the Scottish Government has contacted the MHRA on more than one occasion, most recently at the beginning of October. To date, the alleged use of counterfeit material has not led to any reported adverse events associated with the devices, and the MHRA has not therefore been required to take enforcement action or to issue any device alerts.

In the Official Report

No contribution in the Official Report cites S5W-03445 by reference.